Clinical Trials
3 trialsNCT03681483 2024-07-10
RO5126766 for Patients With Advanced KRAS-Mutant Lung Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT05489731 2023-06-15
VIC-1911
Jiesi Yingda Pharmaceutical Technology (Suzhou) Co., Ltd.
Phase 1 Unknown
NCT04990063 2021-08-04
Adoptive TKC Transfer Combined With Chemotherapy for Advanced Non-small Cell Lung Cancer (NSCLC)
Tang-Du Hospital
Phase 1 Unknown